Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: A pilot study

Pediatric Pulmonology

Volumn 33, Issue 1, 2002, Pages 32-37

  Heinzl, Bernd ^a   Eber, Ernst ^a   Oberwaldner, Béatrice ^a   Haas, Gertrude ^b   Zach, Maximilian S ^a,c  

^a UNIVERSITY OF GRAZ   (Austria)

^b Federal Institute for Bacteriology and Serology   (Austria)

^c Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

Author keywords

Cystic fibrosis; Gentamicin; Inhaled antibiotics; Prophylaxis; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN;

ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE COURSE; DRUG EFFICACY; GRAM NEGATIVE INFECTION; HUMAN; INFANT; INFECTION PREVENTION; LUNG FUNCTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AUSTRIA; CYSTIC FIBROSIS; FEMALE; GENTAMICINS; HUMANS; INFANT; MALE; PILOT PROJECTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0036135429     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10019     Document Type: Article

References (27)

1. Lung disease in cystic fibrosis - An updated concept
2. Cystic fibrosis
3. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: A meta-analysis of benefits and risks
4. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
5. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
6. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis
7. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - Possible synergism with Pseudomonas aeruginosa
8. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis
9. Role of respiratory syncytial virus in early hospitalisations for respiratory distress of young infants with cystic fibrosis
10. Effects of upper respiratory tract infections in patients with cystic fibrosis
11. Severe viral respiratory infections in infants with cystic fibrosis
12. Deterioration in lung function after general anaesthesia in patients with cystic fibrosis
13. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients
14. Early Pseudomonas aeruginosa (PA) colonization in young infants with cystic fibrosis (CF) identified by newborn screening
15. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilising pilocarpine by iontophoresis
16. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests
17. Lung function values from a longitudinal study of healthy children and adolescents
18. The chest roentgenogram in cystic fibrosis: A new scoring system
19. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aentginosa infection in patients with cystic fibrosis
20. Inhalation of antibiotics in cystic fibrosis
21. Quantitative deposition of aerosolized gentamicin in cystic fibrosis
22. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis
23. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis
24. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
25. Urinary N-acetyl-β-D-glucosaminidase activity in patients with cystic fibrosis on long term gentamycin inhalation
26. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa
27. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis